Sleep disturbance as transdiagnostic: Consideration of neurobiological mechanisms

Clinical Psychology Review

Volumn 31, Issue 2, 2011, Pages 225-235

  Harvey, Allison G ^a   Murray, Greg ^b   Chandler, Rebecca A ^a   Soehner, Adriane ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Circadian; Genes; Monoamines; Psychiatric disorder; Sleep; Transdiagnostic

Indexed keywords

DOPAMINE; MELATONIN; NEUROLEPTIC AGENT; PER2 PROTEIN; PROTEIN BMAL1; PROTEIN TIMELESS; SEROTONIN; TRANSCRIPTION FACTOR CLOCK;

ANXIETY; BIPOLAR DISORDER; CIRCADIAN RHYTHM; CLINICAL TRIAL (TOPIC); COGNITIVE THERAPY; COMORBIDITY; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; EMOTION; EMOTIONAL DISORDER; EMOTIONAL STABILITY; HOMEOSTASIS; HUMAN; LIGHT EXPOSURE; MENTAL DISEASE; META ANALYSIS (TOPIC); NEUROBIOLOGY; NONHUMAN; QUALITY OF LIFE; REVIEW; SEASONAL AFFECTIVE DISORDER; SEDATION; SEROTONINERGIC SYSTEM; SIDE EFFECT; SLEEP; SLEEP DISORDER; SLEEP WAKING CYCLE;

CIRCADIAN RHYTHM; HUMANS; SLEEP; SLEEP DISORDERS;

EID: 79951508088     PISSN: 02727358     EISSN: 18737811     Source Type: Journal    
DOI: 10.1016/j.cpr.2010.04.003     Document Type: Review

References (174)

1. Abarca C., Albrecht U., Spanagel R. Cocaine sensitization and reward are under the influence of circadian genes and rhythm. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:9026-9030.
2. Adrien J. Neurobiological bases for the relation between sleep and depression. Sleep Medicine Reviews 2002, 6:341-351.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, APA, Washington, D.C. 4th, text revision ed.
4. Anderson J.L., Glod C.A., Dai J., Cao Y., Lockley S.W. Lux vs. wavelength in light treatment of Seasonal Affective Disorder. Acta Psychiatrica Scandinavica 2009, 120:203-212.
5. Andretic R., Chaney S., Hirsh J. Requirement of circadian genes for cocaine sensitization in Drosophila. Science 1999, 285:1066-1068.
6. Andretic R., Franken P., Tafti M. Genetics of sleep. Annual Review of Genetics 2008, 42:361-388.
7. Armitage R. Microarchitectural findings in sleep EEG in depression: Diagnostic implications. Biological Psychiatry 1995, 37(2):72-84.
8. Armitage R. Sleep and circadian rhythms in mood disorders. Acta Psychiatr Scand 2007, Suppl(433):104-115.
9. Ashby F.G., Isen A.M., Turken A.U. A neuropsychological theory of positive affect and its influence on cognition. Psychological Review 1999, 106:529-550.
10. Bamne M.N., Mansour H., Monk T.H., Buysee D.J., Nimgaonkar V.L. Approaches to unravel the genetics of sleep. Sleep Machine Reviews 2010, 14:397-404.
11. Barbini B., Benedetti F., Colombo C., Dotoli D., Bernasconi A., Cigala-Fulgosi M., et al. Dark therapy for mania: A pilot study. Bipolar Disorders 2005, 7:98-101.
12. Benca R.M., Obermeyer W.H., Thisted R.A., Gillin J.C. Sleep and psychiatric disorders. A meta-analysis. Archives of General Psychiatry 1992, 49:651-668. discussion 669-670.
13. Bergen A.W., Yeager M., Welch R.A., Haque K., Ganjei J.K., van den Bree M.B., et al. Association of multiple DRD2 polymorphisms with anorexia nervosa. Neuropsychopharmacology 2005, 30:1703-1710.
14. Berk M., Berk L., Castle D. A collaborative approach to the treatment alliance in bipolar disorder. Bipolar Disorders 2004, 6:504-518.
15. Berk M., Dodd S., Kauer-Sant'anna M., Malhi G.S., Bourin M., Kapczinski F., et al. Dopamine dysregulation syndrome: Implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatrica Scandinavica 2007, 116( SUPPL. 434):41-49.
16. Bootzin R.R., Epstein D.R. Stimulus control 2000, K.L. Lichstein (Ed.).
17. Borbely A.A. A two process model of sleep regulation. Human Neurobiology 1982, 1:195-204.
18. Brainard G.C., Hanifin J.P. Photons, clocks, and consciousness. Journal of Biological Rhythms 2005, 20:314-325.
19. Bressan R.A., Crippa J.A. The role of dopamine in reward and pleasure behaviour-Review of data from preclinical research. Acta psychiatrica Scandinavica 2005, 111(Suppl. 427):14-21.
20. Cagampang F.R., Yamazaki S., Otori Y., Inouye S.I. Serotonin in the raphe nuclei: Regulation by light and an endogenous pacemaker. Neuroreport 1993, 5:49-52.
21. Cain S.W., Ko C.H., Chalmers J.A., Ralph M.R. Time of day modulation of conditioned place preference in rats depends on the strain of rat used. Neurobiology of Learning and Memory 2004, 81:217-220.
22. Cano G., Mochizuki T., Saper C.B. Neural circuitry of stress-induced insomnia in rats. The Journal of Neuroscience 2008, 28:10167-10184.
23. Carlezon W.A., Thomas M.J. Biological substrates of reward and aversion: A nucleus accumbens activity hypothesis. Neuropharmacology 2009, 56(Suppl. 1):122-132.
24. Cartwright R., Young M.A., Mercer P., Bears M. Role of REM sleep and dream variables in the prediction of remission from depression. Psychiatry Research 1998, 80:249-255.
25. Carver C.S., Johnson S.L., Joormann J. Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: What depression has in common with impulsive aggression. Psychological Bulletin 2008, 134:912-943.
26. Chemerinski E., Ho B.C., Flaum M., Arndt S., Fleming F., Andreasen N.C. Insomnia as a predictor for symptom worsening following antipsychotic withdrawal in schizophrenia. Comprehensive Psychiatry 2002, 43:393-396.
27. Corsini R.J., Wedding D. Current psychotherapies 2005, F.E. Peacock, Itasca, Ill. 7th ed.
28. Craske M.G., Rowe M.K. Nocturnal panic. Clinical Psychology: Science and Practice 1997, 4:153-174.
29. Craske M.G., Tsao J.C. Assessment and treatment of nocturnal panic attacks. Sleep Medicine Reviews 2005, 9:173-184.
30. Czeisler C.A., Duffy J.F., Shanahan T.L., Brown E.N., Mitchell J.F., Rimmer D.W., et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 1999, 284:2177-2181.
31. Dahan L., Astier B., Vautrelle N., Urbain N., Kocsis B., Chouvet G. Prominent burst firing of dopaminergic neurons in the ventral tegmental area during paradoxical sleep. Neuropsychopharmacology 2007, 32:1232-1241.
32. Dahl R.E., Lewin D.S. Pathways to adolescent health sleep regulation and behavior. Journal of Adolescent Health 2002, 31(Suppl. 6):175-184.
33. Dijk D., Franken P. Interaction of sleep homeostasis and circadian rhythmicity: Dependent or independent systems?. Principles and Practice of Sleep Medicine 2005, 418-434. Saunders, Philadelphia. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
34. Dinges D.F., Pack F., Williams K., Gillen K.A., Powell J.W., Ott G.E., et al. Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4-5hours per night. Sleep 1997, 20:267-267.
35. Drake C.L., Roehrs T.A., Burduvali E., Bonahoom A., Rosekind M., Roth T. Effects of rapid versus slow accumulation of eight hours of sleep loss. Psychophysiology 2001, 38:979-987.
36. Dudley C.A., Erbel-Sieler C., Estill S.J., Reick M., Franken P., Pitts S., et al. Altered patterns of sleep and behavioral adaptability in NPAS2-deficient mice. Science 2003, 301:379-383.
37. Dunlop B.W., Nemeroff C.B. The role of dopamine in the pathophysiology of depression. Archives of General Psychiatry 2007, 64:327-337.
38. Ehlers C.L., Frank E., Kupfer D.J. Social zeitgebers and biological rhythms. A unified approach to understanding the etiology of depression. Archives of General Psychiatry 1988, 45:948-952.
39. Eidelman P., Talbot L.S., Gruber J., Hairston I., Harvey A.G. Sleep architecture as a correlate and predictor of symptoms and impairment in inter-episode bipolar disorder: Taking on the challenge of medications. Journal of Sleep Research 2010, 19:516-524.
40. El-Sheikh M., Buckhalt J.A., Cummings E.M., Keller P. Sleep disruptions and emotional insecurity are pathways of risk for children. The Journal of Child Psychology and Psychiatry 2007, 48:88-96.
41. Esposito E. Serotonin-dopamine interaction as a focus of novel antidepressant drugs. Current Drug Targets 2006, 7:177-185.
42. Esposito E., Di Matteo V., Di Giovanni G. Serotonin-dopamine interaction: An overview. Progress in Brain Research 2008, 172:3-6.
43. Even C., Schröder C.M., Friedman S., Rouillon F. Efficacy of light therapy in nonseasonal depression: A systematic review. Journal of Affective Disorders 2008, 108:11-23.
44. Frank E. Treating bipolar disorder: A clinician's guide to interpersonal and social rhythm therapy 2005, Guilford Press, NY.
45. Frank E. Interpersonal and social rhythm therapy: A means of improving depression and preventing relapse in bipolar disorder. Journal of Clinical Psychology: In Session 2007, 63:463-473.
46. Frank E., Kupfer D.J., Ehlers C.L., Monk T.H., Cornes C., Carter S., et al. Interpersonal and social rhythm therapy for bipolar disorder: Integrating interpersonal and behavioral approaches. Behavior Therapist 1994, 17:143-149.
47. Frank E., Kupfer D.J., Thase M.E., Mallinger A.G., Swartz H.A., Eagiolini A.M., et al. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Archives of General Psychiatry 2005, 62:996-1004.
48. Franzen P.L., Siegle G.J., Buysse D.J. Relationships between affect, vigilance, and sleepiness following sleep deprivation. Journal of Sleep Research 2008, 17:34-41.
49. Fuller P.M., Gooley J.J., Saper C.B. Neurobiology of the sleep-wake cycle: Sleep architecture, circadian regulation, and regulatory feedback. Journal of Biological Rhythms 2006, 21:482-493.
50. Garcia J.A., Zhang D., Estill S.J., Michnoff C., Rutter J., Reick M., et al. Impaired cued and contextual memory in NPAS2-deficient mice. Science 2000, 288:2226-2230.
51. Glass J.D., Grossman G.H., Farnbauch L., DiNardo L. Midbrain raphe modulation of nonphotic circadian clock resetting and 5-HT release in the mammalian suprachiasmatic nucleus. The Journal of Neuroscience 2003, 23:7451-7460.
52. Golden R.N., Gaynes B.N., Ekstrom R.D., Hamer R.M., Jacobsen F.M., Suppes T., et al. The efficacy of light therapy in the treatment of mood disorders: A review and meta-analysis of the evidence. The American Journal of Psychiatry 2005, 162:656-662.
53. Goodman A. Neurobiology of addiction. An integrative review. Biochemical Pharmacology 2008, 75:266-322.
54. Grandin L.D., Alloy L.B., Abramson L.Y. The social zeitgeber theory, circadian rhythms, and mood disorders: Review and evaluation. Clinical Psychology Review 2006, 26:679-694.
55. Guile J.M., Huynh C., Desrosiers L., Bouvier H., MacKay J., Chevrier E., et al. Exploring sleep disturbances in adolescent borderline personality disorder using actigraphy: A case report. International Journal of Adolescent Medicine and Health 2009, 21:123-126.
56. Hamilton N.A., Catley D., Karlson C. Sleep and the affective response to stress and pain. Health Psychology 2007, 26:288-295.
57. Hannibal J., Fahrenkrug J. Neuronal input pathways to the brain's biological clock and their functional significance (Vol. 182) 2006, Springer, Berlin.
58. Harvey A.G. Insomnia, psychiatric disorders, and the transdiagnostic perspective. Current Directions in Psychological Science 2008, 17:299-303.
59. Harvey A.G. Sleep and circadian rhythms in bipolar disorder: Seeking synchrony, harmony, and regulation. The American Journal of Psychiatry 2008, 165:820-829.
60. Harvey A.G. The adverse consequences of sleep disturbance in pediatric bipolar disorder: Implications for intervention. Child and Adolescent Psychiatry Clinics of North America 2009, 18(321-338).
61. Harvey A.G. A transdiagnostic approach to treating sleep disturbance in psychiatric disorders. Cognitive Behaviour Therapy 2009, 38(Suppl. 1):35-42.
62. Harvey A.G., Sharpley A.L., Ree M.J., Stinson K., Clark D.M. An open trial of cognitive therapy for chronic insomnia. Behaviour Research and Therapy 2007, 45:2491-2501.
63. Harvey A.G., Watkins E., Mansell W., Shafran R. Cognitive behavioural processes across psychological disorders: A transdiagnostic approach to research and treatment 2004, Oxford University Press, Oxford.
64. Healy D., Waterhouse J.M. The circadian system and the therapeutics of the affective disorders. Pharmacology & Therapeutics 1995, 65:241-263.
65. Hedlund P.B. The 5-HT7 receptor and disorders of the nervous system: An overview. Psychopharmacology (Berl) 2009, 206:345-354.
66. Heidenreich T., Tuin I., Pflug B., Michal M., Michalak J. Mindfulness-based cognitive therapy for persistent insomnia: A pilot study. Psychotherapy and Psychosomatics 2006, 75:188-189.
67. Hirshkowitz M., Moore C.A., O'Connor S., Bellamy M., Cunningham G.R. Androgen and sleep-related erections. Journal of Psychosomatic Research 1997, 42:541-546.
68. Hornung O.P., Regen F., Warnstedt C., Anghelescu I., Danker-Hopfe H., Heuser I., et al. Declarative and procedural memory consolidation during sleep in patients with borderline personality disorder. Journal of Psychiatric Research 2008, 42:653-658.
69. Jiang Z.G., Teshima K., Yang Y., Yoshioka T., Allen C.N. Pre- and postsynaptic actions of serotonin on rat suprachiasmatic nucleus neurons. Brain Research 2000, 866:247-256.
70. Johnson S.L. Mania and dysregulation in goal pursuit: A review. Clinical Psychology Review 2005, 25:241-262.
71. Kantrowitz J., Citrome L., Javitt D. GABA(B) receptors, schizophrenia and sleep dysfunction: A review of the relationship and its potential clinical and therapeutic implications. CNS Drugs 2009, 23:681-691.
72. Kaye W. Neurobiology of anorexia and bulimia nervosa. Physiology and Behavior 2008, 94:121-135.
73. Khan A.A., Jacobson K.C., Gardner C.O., Prescott C.A., Kendler K.S. Personality and comorbidity of common psychiatric disorders. The British Journal of Psychiatry 2005, 186:190-196.
74. Krakow B., Zadra A. Clinical management of chronic nightmares: Imagery rehearsal therapy. Behavioral Sleep Medicine 2006, 4:45-70.
75. Krueger R.F., Markon K.E. Reinterpreting comorbidity: a model-based approach to understanding and classifying psychopathology. Annual Review of Clinical Psychology 2006, 2:111-133.
76. Lambert G.W., Reid C., Kaye D.M., Jennings G.L., Esler M.D. Effect of sunlight and season on serotonin turnover in the brain. The Lancet 2002, 360:1840-1842.
77. Lamont E.W., Legault-Coutu D., Cermakian N., Boivin D.B. The role of circadian clock genes in mental disorders. Dialogues in Clinical Neuroscience 2007, 9:333-342.
78. Lasky-Su J., Neale B.M., Franke B., Anney R.J.L., Zhou K., Maller J.B., et al. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2008, 147B:1345-1354.
79. Lepola U., Koponen H., Leinonen E. Sleep in panic disorders. Journal of Psychosomatic Research 1994, 38(Suppl. 1):105-111.
80. Leproult R., Colecchia E.F., L'Hermite-Baleriaux M., Van Cauter E. Transition from dim to bright light in the morning induces an immediate elevation of cortisol levels. Journal of Clinical Endocrinology and Metabolism 2001, 86:151-157.
81. Lima M.M.S., Andersen M.L., Reksidler A.B., Silva A., Zager A., Zanata S.M., et al. Blockage of dopaminergic D2 receptors produces decrease of REM but not of slow wave sleep in rats after REM sleep deprivation. Behavioural Brain Research 2008, 188:406-411.
82. Lockley S.W., Brainard G.C., Czeisler C.A. High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. The Journal of Clinical Endocrinology and Metabolism 2003, 88:4502-4505.
83. Lotrich F.E., Pollock B.G. Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatric Genetics 2004, 14:121-129.
84. Luddington N.S., Mandadapu A., Husk M., El-Mallakh R.S. Clinical implications of genetic variation in the serotonin transporter promoter region: A review. Primary Care Companion to The Journal of Clinical Psychiatry 2009, 11:93-102.
85. Lyon G.J., Abi-Dargham A., Moore H., Lieberman J.A., Javitch J.A., Sulzer D. Presynaptic regulation of dopamine transmission in schizophrenia. Schizophrenia Bulletin 2009.
86. Malhi G.S., Berk M. Does dopamine dysfunction drive depression?. Acta Psychiatrica Scandinavica 2007, 115(Suppl. 433):116-124.
87. Malkoff-Schwartz S., Frank E., Anderson B., Sherrill J.T., Siegel L., Patterson D., et al. Stressful life events and social rhythm disruption in the onset of manic and depressive bipolar episodes. Archives of General Psychiatry 1998, 55:702-707.
88. Malkoff-Schwartz S., Frank E., Anderson B.P., Hlastala S.A., Luther J.F., Sherrill J.T., et al. Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes. Psychological Medicine 2000, 30:1005-1016.
89. Mansour H.A., Monk T.H., Nimgaonkar V.L. Circadian genes and bipolar disorder. Annals of Medicine 2005, 37:196-205.
90. Mansour H.A., Wood J., Logue T., Chowdari K.V., Dayal M., Kupfer D.J., et al. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes, Brain and Behavior 2006, 5:150-157.
91. Martin-Soelch C. Is depression associated with dysfunction of the central reward system?. Biochemical Society Transactions 2009, 37:313-317.
92. Matsuura H., Tateno K., Aou S. Dynamical properties of the two-process model for sleep-wake cycles in infantile autism. Cognitive Neurodynamics 2008, 2:221-228.
93. McClung C.A., Sidiropoulou K., Vitaterna M., Takahashi J.S., White F.J., Cooper D.C., et al. Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:9377-9381.
94. McHugh, R. K., Murray, H. W., & Barlow, D. H. Balancing fidelity and adaptation in the dissemination of empirically-supported treatments: The promise of transdiagnostic interventions. Behaviour Research and Therapy, In Press, Corrected Proof.
95. Michalak E.E., Murray G., Wilkinson C., Dowrick C., Lam R.W. A pilot study of adherence with light treatment for seasonal affective disorder. Psychiatry Research 2007, 149:315-320.
96. Miklowitz D.J., Goodwin G.M., Bauer M.S., Geddes J.R. Common and specific elements of psychosocial treatments for bipolar disorder: A survey of clinicians participating in randomized trials. Journal of Psychiatric Practice 2008, 14:77-85.
97. Miklowitz D.J., Otto M.W., Frank E., Reilly-Harrington N.A., Wisniewski S.R., Kogan J.N., et al. Psychosocial treatments for bipolar depression: A 1-year randomized trial from the systematic treatment enhancement program. Archives of General Psychiatry 2007, 64:419-426.
98. Miller J.D., Morin L.P., Schwartz W.J., Moore R.Y. New insights into the mammalian circadian clock. Sleep 1996, 19:641-667.
99. Mistlberger R.E., Antle M.C., Glass J.D., Miller J.D. Behavioral and serotonergic regulation of circadian rhythms. Biological Rhythm Research 2000, 31:240-283.
100. Moghaddam B. Stress activation of glutamate neurotransmission in the prefrontal cortex: Implications for dopamine-associated psychiatric disorders. Biological Psychiatry 2002, 51:775-787.
101. Monk T.H., Petrie S.R., Hayes A.J., Kupfer D.J. Regularity of daily life in relation to personality, age, gender, sleep quality and circadian rhythms. Journal of Sleep Research 1994, 3:196-205.
102. Monteleone P., Tortorella A., Docimo L., Maldonato M.N., Canestrelli B., De Luca L., et al. Investigation of 3111T/C polymorphism of the CLOCK gene in obese individuals with or without binge eating disorder: Association with higher body mass index. Neuroscience Letters 2008, 435:30-33.
103. Monti J.M., Monti D. The involvement of dopamine in the modulation of sleep and waking. Sleep Medicine Reviews 2007, 11:113-133.
104. Moore R.Y. Entrainment pathways and the functional organization of the circadian system. Progress in Brain Research 1996, 111:103-119.
105. Moore R.Y. Suprachiasmatic nucleus in sleep-wake regulation. Sleep Medicine 2007, 8(Suppl. 3):27-33.
106. Morin C.M., Bootzin R.R., Buysse D.J., Edinger J.D., Espie C.A., Lichstein K.L. Psychological and behavioral treatment of insomnia: An update of recent evidence (1998-2004). Sleep 2006, 29:1396-1406.
107. Morin L.P. Serotonin and the regulation of mammalian circadian rhythmicity. Annals of Medicine 1999, 31:12-33.
108. Moyer R.W., Kennaway D.J. Serotonin depletion decreases light induced c-fos in the rat suprachiasmatic nucleus. Neuroreport 2000, 11:1021-1024.
109. Mrosovsky N. Critical assessment of methods and concepts in nonphotic phase shifting. Biological Rhythm Research 1999, 30:135-148.
110. Murray, G. (in press). Circadian and sleep/wake considerations in the practical management of bipolar disorder. In A. Young, N. Ferrier & E. E. Michalak (Eds.), Practical management of bipolar disorder. Cambridge: Cambridge University Press.
111. Murray G., Harvey A. Circadian rhythms and sleep in bipolar disorder. In L. N. Yatham & M. Maj (Eds.). Bipolar Disorder: Clinical and Neurobiological Foundations. NY: John Wiley & Sons 2010, 12:459-472.
112. Murray G., Nicholas C.L., Kleiman J., Dwyer R., Carrington M.J., Allen N.B., et al. Nature's clocks and human mood: The circadian system modulates reward motivation. Emotion 2009, 9:705-716.
113. Nagayama H. Influences of biological rhythms on the effects of psychotropic drugs. Psychosomatic Medicine 1999, 61:618-629.
114. Nicholas B., Rudrasingham V., Nash S., Kirov G., Owen M.J., Wimpory D.C. Association of Per1 and Npas2 with autistic disorder: Support for the clock genes/social timing hypothesis. Molecular Psychiatry 2007, 12:581-592.
115. NIH National Institutes of Health State of the Science Conference Statement: Manifestations and management of chronic insomnia in adults. June 13-15, 2005. Sleep 2005, 28:1049-1057.
116. Novati A., Roman V., Cetin T., Hagewoud R., den Boer J.A., Luiten P.G., et al. Chronically restricted sleep leads to depression-like changes in neurotransmitter receptor sensitivity and neuroendocrine stress reactivity in rats. Sleep 2008, 31:1579-1585.
117. Olijslagers J., Werkman T., McCreary A., Kruse C., Wadman W. Modulation of midbrain dopamine neurotransmission by serotonin, a versatile interaction between neurotransmitters and significance for antipsychotic drug action. Current Neuropharmacology 2006, 4:59-68.
118. Ong J.C., Shapiro S.L., Manber R. Combining mindfulness meditation with cognitive-behavior therapy for insomnia: A treatment-development study. Behavior Therapy 2008, 39:171-182.
119. Ongini E., Bonizzoni E., Ferri N., Milani S., Trampus M. Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat. Journal of Pharmacology and Experimental Therapeutics 1993, 266:726-731.
120. Oren D.A., Cubells J.F., Litsch S. Bright light therapy for schizoaffective disorder. The American Journal of Psychiatry 2001, 158:2086-2087.
121. Oren D.A., Wisner K.L., Spinelli M., Epperson C.N., Peindl K.S., Terman J.S., et al. An open trial of morning light therapy for treatment of antepartum depression. The American Journal of Psychiatry 2002, 159:666-669.
122. Partonen T., Treutlein J., Alpman A., Frank J., Johansson C., Depner M., et al. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Annals of Medicine 2007, 39:229-238.
123. Phelps J. Dark therapy for bipolar disorder using amber lenses for blue light blockade. Medical Hypotheses 2008, 70:224-229.
124. Prosser R.A. Serotonergic actions and interactions on the SCN circadian pacemaker: In vitro investigations. Biological Rhythm Research 2000, 31:315-339.
125. Ralph M.R., Ko C.H., Antoniadis E.A., Seco P., Irani F., Presta C., et al. The significance of circadian phase for performance on a reward-based learning task in hamsters. Behavioural Brain Research 2002, 136:179-184.
126. Redfern P.H., Waterhouse J.M., Minors D.S. Circadian rhythms: Principles and measurement. Pharmacology & Therapeutics 1991, 49:311-327.
127. Ree M., Harvey A.G. Investigating safety behaviours in insomnia: The Development of the Sleep-related Behaviours Questionnaire (SRBQ). Behaviour Change 2004, 21:26-36.
128. Reghunandanan V., Reghunandanan R. Neurotransmitters of the suprachiasmatic nuclei. Journal of Circadian Rhythms 2006, 4:2.
129. Reick M., Garcia J.A., Dudley C., McKnight S.L. NPAS2: An analog of clock operative in the mammalian forebrain. Science 2001, 293:506-509.
130. Reme C.E., Wirz-Justice A., Terman M. The visual input stage of the mammalian circadian pacemaking system: I. Is there a clock in the mammalian eye?. Journal of Biological Rhythms 1991, 6:5-29.
131. Reppert S.M., Weaver D.R. Coordination of circadian timing in mammals. Nature 2002, 418:935-941.
132. Richtand N.M., McNamara R.K. Serotonin and dopamine interactions in psychosis prevention. Progress in Brain Research 2008, 172:141-153.
133. Richtand N.M., Welge J.A., Logue A.D., Keck P.E., Strakowski S.M., McNamara R.K. Role of serotonin and dopamine receptor binding in antipsychotic efficacy. Progress in Brain Research 2008, 172:155-175.
134. Roennebert T., Foster R.G. Twilight times: Light and the circadian system. Photochemistry and Photobiology 1997, 66:549-561.
135. Roman V., Walstra I., Luiten P.G., Meerlo P. Too little sleep gradually desensitizes the serotonin 1A receptor system. Sleep 2005, 28:1505-1510.
136. Roth T., Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. II. Sleep 1999, 22(Suppl. 2):S354-S358.
137. Roybal K., Theobold D., Graham A., DiNieri J.A., Russo S.J., Krishnan V., et al. Mania-like behavior induced by disruption of CLOCK. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:6406-6411.
138. Saper C.B., Cano G., Scammell T.E. Homeostatic, circadian, and emotional regulation of sleep. Journal of Comprehensive Neurology 2005, 493:92-98.
139. Saper C.B., Chou T.C., Scammell T.E. The sleep switch: Hypothalamic control of sleep and wakefulness. Trends in Neurosciences 2001, 24:726-731.
140. Schumann G. Okey Lecture 2006: Identifying the neurobiological mechanisms of addictive behaviour. Addiction 2007, 102:1689-1695.
141. Serretti A., Benedetti F., Mandelli L., Lorenzi C., Pirovano A., Colombo C., et al. Genetic dissection of psychopathological symptoms: Insomnia in mood disorders and CLOCK gene polymorphism. American Journal Medical Genetics 2003, 121B:35-38.
142. Shneerson J.M. Handbook of sleep medicine 2000, Blackwell Science, Oxford.
143. Sit D., Wisner K.L., Hanusa B.H., Stull S., Terman M. Light therapy for bipolar disorder: A case series in women. Bipolar Disorders 2007, 9:918-927.
144. Sleipness E.P., Sorg B.A., Jansen H.T. Time of day alters long-term sensitization to cocaine in rats. Brain Research 2005, 1065:132-137.
145. Sleipness E.P., Sorg B.A., Jansen H.T. Diurnal differences in dopamine transporter and tyrosine hydroxylase levels in rat brain: Dependence on the suprachiasmatic nucleus. Brain Research 2007, 1129:34-42.
146. Snyder S.H., Borjigin J., Sassone-Corsi P. Discovering light effects on the brain. The American Journal of Psychiatry 2006, 163:771.
147. Spanagel R., Pendyala G., Abarca C., Zghoul T., Sanchis-Segura C., Magnone M.C., et al. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nature Medicine 2005, 11:35-42.
148. Sprouse J. Pharmacological modulation of circadian rhythms: A new drug target in psychotherapeutics. Expert Opinion on Therapeutic Targets 2004, 8:25-38.
149. Sprouse J., Braselton J., Reynolds L. Fluoxetine modulates the circadian biological clock via phase advances of suprachiasmatic nucleus neuronal firing. Biological Psychiatry 2006, 60:896-899.
150. Stein M.B., Kroft C.D., Walker J.R. Sleep impairment in patients with social phobia. Psychiatry Research 1993, 49:251-256.
151. Stunkard A., Allison K., Lundgren J. Issues for DSM-V: Night eating syndrome. The American Journal of Psychiatry 2008, 165:424.
152. Suto M., Murray G., Hale S., Amari E., Michalak E. What Works for People with Bipolar Disorder? Tips from the Experts. Journal of Affective Disorders 2010, 124:76-84.
153. Takahashi J.S., Hong H.K., Ko C.H., McDearmon E.L. The genetics of mammalian circadian order and disorder: Implications for physiology and disease. Nature Reviews Genetics 2008, 9:764-775.
154. Takao T., Tachikawa H., Kawanishi Y., Mizukami K., Asada T. CLOCK gene T3111C polymorphism is associated with Japanese schizophrenics: A preliminary study. European Neuropsychopharmacology 2007, 17:273-276.
155. Terman J.S., Terman M., Schlager D., Rafferty B., Rosofsky M., Link M.J., et al. Efficacy of brief, intense light exposure for treatment of winter depression. Psychopharmacology Bulletin 1990, 26:3-11.
156. Terman M., Levine S.M., Terman J.S., Doherty S. Chronic fatigue syndrome and seasonal affective disorder: Comorbidity, diagnostic overlap, and implications for treatment. The American Journal of Medicine 1998, 105:115S-124S.
157. Tortorella A., Monteleone P., Martiadis V., Perris F., Maj M. The 3111T/C polymorphism of the CLOCK gene confers a predisposition to a lifetime lower body weight in patients with anorexia nervosa and bulimia nervosa: A preliminary study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2007, 144B:992-995.
158. Tuunainen A., Kripke D.F., Endo T. Light therapy for non-seasonal depression (Cochrane Review). The Cochrane Library 2006, 2.
159. Ursin R. Serotonin and sleep. Sleep Medicine Reviews 2002, 6:55-69.
160. Van Sweden B. Disturbed vigilance in mania. Biological Psychiatry 1986, 21:311-313.
161. Vandewalle G., Gais S., Schabus M., Balteau E., Carrier J., Darsaud A., et al. Wavelength-dependent modulation of brain responses to a working memory task by daytime light exposure. Cerebral Cortex 2007, 17:2788-2795.
162. Vandewalle G., Schmidt C., Albouy G.v., Sterpenich V., Darsaud A., Rauchs G.r., et al. Brain responses to violet, blue, and green monochromatic light exposures in humans: Prominent role of blue light and the brainstem. PLoS ONE 2007, 2:e1247.
163. Vaswani M., Linda F.K., Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: A comprehensive review. Progress in neuro-psychopharmacology and biological psychiatry 2003, 27:85-102.
164. Walker E., Mittal V., Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annual Review of Clinical Psychology 2008, 4:189-216.
165. Walker M.P., Stickgold R. Sleep, memory, and plasticity. Annu Rev Psychol 2006, 57:139-166.
166. Wirz-Justice A., Benedetti F., Berger M., Lam R.W., Martiny K., Terman M., et al. Chronotherapeutics (light and wake therapy) in affective disorders. Psychological Medicine 2005, 35:939-944.
167. Wirz-Justice A., Benedetti F., Terman M. Chronotherapeutics for affective disorders: A clinician's manual for light & wake therapy 2009, Karger, Basel. 1 ed.
168. Wirz-Justice A., Terman M., Oren D.A., Goodwin F.K., Kripke D.F., Whybrow P.C., et al. Brightening depression. Science 2004, 303:467-469.
169. Wisor J.P., Nishino S., Sora I., Uhl G.H., Mignot E., Edgar D.M. Dopaminergic role in stimulant-induced wakefulness. The Journal of Neuroscience 2001, 21:1787-1794.
170. Yan L., Bobula J.M., Svenningsson P., Greengard P., Silver R. DARPP-32 involvement in the photic pathway of the circadian system. The Journal of Neuroscience 2006, 26:9434-9438.
171. Yoo S.S., Gujar N., Hu P., Jolesz F.A., Walker M.P. The human emotional brain without sleep-A prefrontal amygdala disconnect. Current Biology 2007, 17:R877-R878.
172. Yoshida K., McCormack S., Espana R.A., Crocker A., Scammell T.E. Afferents to the orexin neurons of the rat brain. The Journal of Comparative Neurology 2006, 494:845-861.
173. Yuan Q., Lin F., Zheng X., Sehgal A. Serotonin modulates circadian entrainment in Drosophila. Neuron 2005, 47:115-127.
174. Zohar D., Tzischinsky O., Epsten R., Lavie P. The effects of sleep loss on medical residents' emotional reactions to work events: A cognitive-energy model. Sleep 2005, 28:47-54.